TxCell Company
TxCell develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases.
Technology:
Anti-infective Drugs
Headquarters:
Valbonne, Provence-Alpes-Cote d'Azur, France
Funding Status:
M&A
Founded Date:
2001-01-01
Last Funding Type:
Debt Financing
Investors Number:
1
Estimated Revenue:
Less than $1M
Employee Number:
51-100
Total Funding:
$6.3M
Industry:
PharmTech
Investor Type:
For Profit